| IOVA |    | Iovance Biotherapeutics, Inc. - Common Stock | | | -2.06% down 15.46% -17.52 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1425205/000110465925067940/0001104659-25-067940-index.htm
8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer) | + My List |
| CNTB | | Connect Biopharma Holdings Limited - American Depositary Shares | | | 11.64% 11.64% 0 | | + Biopharma, Country: China, T cell-based
Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1835268/000162828025034551/0001628280-25-034551-index.htm
8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | 2.86% 2.86% 0 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1840748/000110465925059366/0001104659-25-059366-index.htm
8-K - LAVA Therapeutics NV (0001840748) (Filer) | + My List |
| BTMD | | Biote Corp. - Class A common stock | | | 8.88% 8.88% 0 | | + T cell-based, Biotechnology, Immunology, Medicine
| + My List |
